Lee Arphing
Transaction: 11/07/2025
OTHER
Change
0
Price
Not reported
Filing
11/19/2025
Type
OTHER
iSpecimen Inc.
ISPC • Medical - Diagnostics & Research
$1.54
— 0.00 (0.00%)
Current price
EarningsLatest report: Jun 30, 2026
HIGHER-RISK PROFILECautionConfidence: 70%
Quantitative profile — not an investment recommendation.
Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Caution is warranted. Recent ratios show weaknesses that may limit returns unless fundamentals improve.
Market Cap
$21,473.76
Growth
-53.8%
Cash Flow
0/5
Trend
Negative
Evidence
Manageable debt level · 0.09Negative growth trendWeak profitability
Financial data as of: Jun 30, 2026, 12:00 AM UTCLast earnings update: Jun 30, 2026, 12:00 AM UTCLast profile update: Aug 16, 2026, 12:25 PM UTC
Company Snapshot
Key valuation, quality, financial strength, momentum and analyst data.
Price$1.54
Change0.00%
Shares Out13.94K
Market Cap$21.47K
Enterprise Value$-4.15M
52W Range1.77 - 127.20
Beta1.64
P/E-0.00
P/S0.05
P/B0.01
P/FCF-0.00
EV/Sales-8.90
Price$1.54
Change0.00%
Shares Out13.94K
Market Cap$21.47K
Enterprise Value$-4.15M
52W Range1.77 - 127.20
Beta1.64
P/E-0.00
P/S0.05
P/B0.01
P/FCF-0.00
EV/Sales-8.90
EV/EBITDA0.40
EV/FCF0.59
Dividend Yield0.00%
Gross Margin1.25%
Oper. Margin-4.65%
Profit Margin-5.44%
Debt/Eq0.09
Current Ratio1.12
Quick Ratio1.12
Revenue 5Y-53.84%
Volume37.87K
Avg Volume161.53K
EPS Surprise128.40
Investment DNA
How strong this company looks for long-term investors
40
out of 100
Business Quality
Margins, moat, returns
22/100
Financial Strength
Debt, cash, stability
61/100
Growth Potential
Revenue and expansion
20/100
Price Attractiveness
Cheap or expensive today
95/100
Why this score▼
Manageable debt level · 0.09Negative growth trendWeak profitability
Analyst view
Analyst sentiment and price target
Analyst sentiment
Based on 2 analyst votes · 2026-09-05
100/100
Bullish
Bullish
2
Hold
0
Bearish
0
Insider Transactions
Recent executive and insider activity
Liang Yuying
Transaction: 12/13/2024
OTHER
Change
0
Price
Not reported
Filing
01/30/2025
Type
OTHER
LIM ROBERT BRADLEY
Transaction: 12/09/2024
OTHER
Change
0
Price
Not reported
Filing
12/13/2024
Type
OTHER
| Insider | Type | Change | Price | Transaction | Filing |
|---|---|---|---|---|---|
| Lee Arphing | OTHER | 0 | Not reported | 11/07/2025 | 11/19/2025 |
| Liang Yuying | OTHER | 0 | Not reported | 12/13/2024 | 01/30/2025 |
| LIM ROBERT BRADLEY | OTHER | 0 | Not reported | 12/09/2024 | 12/13/2024 |
| Dhaliwal Avtar | OTHER | 0 | Not reported | 09/25/2024 | 09/30/2024 |
| Dhaliwal Avtar | BUY | +168 | $5.12 | 09/25/2024 | 09/30/2024 |
| Field Katharyn | OTHER | 0 | Not reported | 09/25/2024 | 09/27/2024 |
| Paolone Richard | OTHER | 0 | Not reported | 09/25/2024 | 09/27/2024 |
| Field Katharyn | BUY | +168 | $5.12 | 09/25/2024 | 09/27/2024 |
| Paolone Richard | BUY | +168 | $5.12 | 09/25/2024 | 09/27/2024 |
| Graham Elizabeth Ames | BUY | +8,340 | $0.28 | 03/21/2024 | 05/20/2024 |
| Brooks John L. III | BUY | +10,000 | $0.53 | 01/02/2024 | 05/20/2024 |
| Gullans Steven R. Ph.D. | BUY | +10,000 | $0.53 | 01/02/2024 | 05/20/2024 |
| Mock Theresa L | BUY | +10,000 | $0.53 | 01/02/2024 | 05/20/2024 |
| Ross Andrew L. | BUY | +10,000 | $0.53 | 01/02/2024 | 05/20/2024 |
| Graham Elizabeth Ames | OTHER | 0 | Not reported | 03/21/2024 | 03/26/2024 |
| Mock Theresa L | OTHER | 0 | Not reported | 12/31/2023 | 02/08/2024 |
| Bielak Benjamin | BUY | +18,000 | $0.72 | 09/14/2023 | 09/15/2023 |
| Curley Tracy | BUY | +4,400 | $1.25 | 05/31/2023 | 06/01/2023 |
| Gullans Steven R. Ph.D. | BUY | +125 | Not reported | 01/01/2023 | 05/17/2023 |
| Ross Andrew L. | BUY | +125 | Not reported | 01/01/2023 | 05/17/2023 |